tiprankstipranks
Trending News
More News >
Immunovant, Inc. (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Revenue

Compare
921 Followers

Immunovant Revenue

Immunovant had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Immunovant had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
362
Market Cap
$5.27B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018